Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
9.30
+0.06 (0.65%)
Aug 27, 2026, 12:30 PM EDT - Market open

Advanced Biomed Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
1515----
Market Cap Growth
47.95%-----
Enterprise Value
1312----
Last Close Price
9.2414.00----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PB Ratio
1.394.36----
P/TBV Ratio
1.664.36----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.080.360.550.180.130.01
Net Debt / Equity Ratio
-0.21-0.47-1.02-1.83-1.24-0.06
Net Debt / EBITDA Ratio
0.650.610.790.841.910.03
Net Debt / FCF Ratio
0.650.280.770.752.650.12
Quick Ratio
1.901.091.030.851.652.34
Current Ratio
7.382.091.120.851.6732.22
Return on Equity (ROE)
71.33%-126.79%-187.43%-155.62%-180.30%-
Return on Assets (ROA)
-21.50%-34.42%-35.07%-33.93%-38.45%-
Return on Capital Employed (ROCE)
-35.30%-83.40%-147.10%-231.90%-63.80%-187.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
34.59%-21.51%----
FCF Yield
-19.28%-38.66%----
Buyback Yield / Dilution
-12.53%-2.63%-0.32%-40.55%-23.74%-
SEC Filings: 10-K · 10-Q